U.S. Peripheral Liquid Embolic Agents Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2036

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Liquid Embolic Agents Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of peripheral artery disease and other vascular disorders in the U.S.
    • 3.2.1.2. Increasing adoption of minimally invasive endovascular embolization procedures
    • 3.2.1.3. Increasing cancer burden in the country driving interventional oncology
    • 3.2.1.4. Continuous innovation in liquid embolic technologies
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of liquid embolic agents and associated procedure costs
    • 3.2.2.2. Limited reimbursement for selected peripheral embolization procedures
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of peripheral embolization applications beyond oncology
    • 3.2.3.2. Increasing adoption of embolization in trauma and emergency hemorrhage management
    • 3.2.3.3. Growth in outpatient embolization across ambulatory surgical centers
    • 3.2.3.4. Development of AI-guided and image-guided embolization technologies
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Risk of non-target embolization and procedure-related complications
    • 3.2.4.2. Shortage of skilled interventional radiologists and endovascular specialists
• 3.3. U.S. Peripheral Liquid Embolic Agents Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. U.S. Peripheral Liquid Embolic Agents Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Peripheral Liquid Embolic Agents Market: Product Movement Analysis, 2025 & 2036 (USD Million)
• 4.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Product, 2021 to 2036 (USD Million)
• 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
  • 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 4.5. Other Embolic Agents
  • 4.5.1. Other Embolic Agents market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 5. U.S. Peripheral Liquid Embolic Agents Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Peripheral Liquid Embolic Agents Market: Application Movement Analysis, 2025 & 2036 (USD Million)
• 5.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Application 2021 to 2036 (USD Million)
• 5.4. Peripheral Vascular Hemorrhage
  • 5.4.1. Peripheral Vascular Hemorrhage market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.5. Hypervascular Tumors
  • 5.5.1. Hypervascular Tumors market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.6. Peripheral Vascular Malformations / AVMs
  • 5.6.1. Peripheral Vascular Malformations/AVMs market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.7. Aneurysms / Pseudoaneurysms
  • 5.7.1. Aneurysms / Pseudoaneurysms market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.8. Type II Endoleaks
  • 5.8.1. Type II Endoleaks market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.9. Portal Vein Embolization (PVE)
  • 5.9.1. Portal Vein Embolization (PVE)market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.10. Venous Applications (varicocele, PCS, varicose veins)
  • 5.10.1. Venous Applications (varicocele, PCS, varicose veins) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 5.11. Other Peripheral Embolization Applications
  • 5.11.1. Other Peripheral Embolization Applications market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 6. U.S. Peripheral Liquid Embolic Agents Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global U.S. Peripheral Liquid Embolic Agents Market: End Use Movement Analysis, 2025 & 2036 (USD Million)
• 6.3. Global U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by End Use, 2021 to 2036 (USD Million)
• 6.4. Hospitals & Interventional Radiology (IR) Suites
  • 6.4.1. Hospitals & Interventional Radiology (IR) Suites market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 6.5. Ambulatory Surgical Centers (ASCs)
  • 6.5.1. Ambulatory Surgical Centers (ASCs) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 6.6. Specialty Clinics / Vascular Centers
  • 6.6.1. Specialty Clinics / Vascular Centers market revenue estimates and forecasts, 2021 - 2036 (USD Million)
• 6.7. Others
  • 6.7.1. Others market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Share Analysis, 2025
• 7.4. Company Heat Map Analysis
• 7.5. Strategy Mapping
  • 7.5.1. Expansion
  • 7.5.2. Mergers & Acquisition
  • 7.5.3. Partnerships & Collaborations
  • 7.5.4. New Technology Launches
  • 7.5.5. Research And Development
  • 7.5.6. Company Profiles
  • 7.5.7. Boston Scientific Corporation
    • 7.5.7.1. Company overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. Terumo Medical Corporation (MicroVention)
    • 7.5.8.1. Company overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. BlackSwan Vascular (Sirtex Medical)
    • 7.5.9.1. Company overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic initiatives
  • 7.5.10. Instylla, Inc.
    • 7.5.10.1. Company overview
    • 7.5.10.2. Financial performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviation
• Table 2 U.S. peripheral liquid embolic agents market, by product, 2021 - 2036 (USD Million)
• Table 3 U.S. peripheral liquid embolic agents market, by application, 2021 - 2036 (USD Million)
• Table 4 U.S. peripheral liquid embolic agents market, by end use, 2021 - 2036 (USD Million)

List of Figures

• Fig. 1 U.S. peripheral liquid embolic agents market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Data analysis models
• Fig. 5 Market formulation and validation
• Fig. 6 Data validating & publishing
• Fig. 7 Market snapshot
• Fig. 8 Segment snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 U.S. peripheral liquid embolic agents market size and growth prospects (USD Million)
• Fig. 11 U.S. peripheral liquid embolic agents market: Industry Value Chain Analysis
• Fig. 12 U.S. peripheral liquid embolic agents market: Market Dynamics
• Fig. 13 U.S. peripheral liquid embolic agents market: PORTER's Analysis
• Fig. 14 U.S. peripheral liquid embolic agents market: PESTEL Analysis
• Fig. 15 U.S. peripheral liquid embolic agents market share by product, 2025 & 2036 (USD Million)
• Fig. 16 U.S. peripheral liquid embolic agents market, by product: market share, 2025 & 2036
• Fig. 17 Ethylene Vinyl Alcohol Copolymer (EVOH) market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 18 Other liquid embolics market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 19 U.S. peripheral liquid embolic agents market share by application, 2025 & 2036 (USD Million)
• Fig. 20 U.S. peripheral liquid embolic agents market, by application: market share, 2025 & 2036
• Fig. 21 Peripheral vascular hemorrhage market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 22 Hypervascular tumors market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 23 Peripheral vascular malformations / AVMs market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 24 Aneurysms / pseudoaneurysms market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 25 Type II endoleaks market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 26 Portal Vein Embolization (PVE) market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 27 Venous applications (varicocele, PCS, varicose veins) market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 28 Other peripheral embolization applications market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 29 U.S. peripheral liquid embolic agents market share by end use, 2025 & 2036 (USD Million)
• Fig. 30 U.S. peripheral liquid embolic agents market, by end use: market share, 2025 & 2036
• Fig. 31 Hospitals & Interventional Radiology (IR) suites market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 32 Ambulatory Surgical Centers (ASCs) market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 33 Specialty clinics / vascular centers market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 34 Others market estimates & forecasts, 2021 - 2036 (USD Million)
• Fig. 35 Key company categorization
• Fig. 36 Company market positioning
• Fig. 37 Key company market share analysis, 2025
• Fig. 38 Strategic framework